Zoledronic acid improves disease-free survival in hormone-responsive early breast cancer

Matt Stenger; Hamid Mirshahidi

doi:10.1016/s1548-5315(11)70369-2

Zoledronic acid improves disease-free survival in hormone-responsive early breast cancer

Hematology/Oncology Division

Research output: Contribution to journal › Short survey › peer-review

Original language	English
Pages (from-to)	11-12
Number of pages	2
Journal	Community Oncology
Volume	6
Issue number	1
DOIs	https://doi.org/10.1016/s1548-5315(11)70369-2
State	Published - Jan 2009

ASJC Scopus Subject Areas

Hematology
Oncology

Access to Document

10.1016/s1548-5315(11)70369-2

OpenUrl availability

Full text

Cite this

@article{353fab4b23204ccbad341a3ba44d1492,

title = "Zoledronic acid improves disease-free survival in hormone-responsive early breast cancer",

author = "Matt Stenger and Hamid Mirshahidi",

year = "2009",

month = jan,

doi = "10.1016/s1548-5315(11)70369-2",

language = "English",

volume = "6",

pages = "11--12",

journal = "Community Oncology",

issn = "1548-5315",

number = "1",

}

TY - JOUR

T1 - Zoledronic acid improves disease-free survival in hormone-responsive early breast cancer

AU - Stenger, Matt

AU - Mirshahidi, Hamid

PY - 2009/1

Y1 - 2009/1

UR - http://www.scopus.com/inward/record.url?scp=60049084170&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=60049084170&partnerID=8YFLogxK

U2 - 10.1016/s1548-5315(11)70369-2

DO - 10.1016/s1548-5315(11)70369-2

M3 - Short survey

AN - SCOPUS:60049084170

SN - 1548-5315

VL - 6

SP - 11

EP - 12

JO - Community Oncology

JF - Community Oncology

IS - 1

ER -

Zoledronic acid improves disease-free survival in hormone-responsive early breast cancer

ASJC Scopus Subject Areas

Access to Document

OpenUrl availability

Other files and links

Cite this